The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds
- PMID: 34484639
- PMCID: PMC8377408
- DOI: 10.18502/ajmb.v13i3.6370
The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds
Abstract
Background: The cause of COVID-19 global pandemic is SARS-CoV-2. Given the outbreak of this disease, it is so important to find a treatment. One strategy to cope with COVID-19 is to use the active ingredients of medicinal plants. In this study, the effect of active substances was surveyed in inhibiting four important druggable targets, including S protein, 3CLpro, RdRp, and N protein. RdRp controls the replication of SARS-CoV-2 and is crucial for its life cycle. 3CLpro is the main protease of the virus and could be another therapeutic target. Moreover, N protein and S protein are responsible for SARS-CoV-2 assembly and attaching, respectively.
Methods: The 3D structures of herbal active ingredients were prepared and docked with the mentioned SARS-CoV-2 proteins to obtain their affinity. Then, available antiviral drugs introduced in other investigations were docked using similar tools and compared with the results of this study. Finally, other properties of natural compounds were uncovered for drug designing.
Results: The outcomes of the study revealed that Linarin, Amentoflavone, (-)-Catechin Gallate and Hypericin from Chrysanthemum morifolium, Hypericum perforatum, Humulus lupulus, and Hibiscus sabdariffa had the highest affinity for these basic proteins and in some cases, their affinity was much higher than antiviral medicines.
Conclusion: In addition to having high affinity, these herb active ingredients have antioxidant, vasoprotective, anticarcinogenic, and antiviral properties. Therefore, they can be used as extremely safe therapeutic compounds in drug design studies to control COVID-19.
Keywords: COVID-19; Drug design; Medicinal plants; SARS-CoV-2.
Copyright© 2021 Avicenna Research Institute.
Conflict of interest statement
Conflict of Interest Authors declare no conflict of interest.
Figures

Similar articles
-
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2.Pharmaceuticals (Basel). 2022 Apr 25;15(5):530. doi: 10.3390/ph15050530. Pharmaceuticals (Basel). 2022. PMID: 35631357 Free PMC article.
-
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2.Int J Biol Macromol. 2021 Apr 15;176:1-12. doi: 10.1016/j.ijbiomac.2021.02.012. Epub 2021 Feb 4. Int J Biol Macromol. 2021. PMID: 33548314 Free PMC article.
-
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130. Curr Pharm Des. 2021. PMID: 34225607 Review.
-
In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.Mol Divers. 2022 Apr;26(2):1053-1076. doi: 10.1007/s11030-021-10230-6. Epub 2021 Jul 2. Mol Divers. 2022. PMID: 34213728 Free PMC article.
-
Potential of amentoflavone with antiviral properties in COVID-19 treatment.Asian Biomed (Res Rev News). 2021 Aug 20;15(4):153-159. doi: 10.2478/abm-2021-0020. eCollection 2021 Aug. Asian Biomed (Res Rev News). 2021. PMID: 37551327 Free PMC article. Review.
Cited by
-
Applications of some advanced sequencing, analytical, and computational approaches in medicinal plant research: a review.Mol Biol Rep. 2023 Dec 20;51(1):23. doi: 10.1007/s11033-023-09057-1. Mol Biol Rep. 2023. PMID: 38117315 Review.
-
Linarin, a Glycosylated Flavonoid, with Potential Therapeutic Attributes: A Comprehensive Review.Pharmaceuticals (Basel). 2021 Oct 29;14(11):1104. doi: 10.3390/ph14111104. Pharmaceuticals (Basel). 2021. PMID: 34832886 Free PMC article. Review.
-
Point-specific interactions of isovitexin with the neighboring amino acid residues of the hACE2 receptor as a targeted therapeutic agent in suppressing the SARS-CoV-2 influx mechanism.J Adv Vet Anim Res. 2022 Jun 26;9(2):230-240. doi: 10.5455/javar.2022.i588. eCollection 2022 Jun. J Adv Vet Anim Res. 2022. PMID: 35891654 Free PMC article.
-
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2.Pharmaceuticals (Basel). 2022 Apr 25;15(5):530. doi: 10.3390/ph15050530. Pharmaceuticals (Basel). 2022. PMID: 35631357 Free PMC article.
-
Role of Technology in Detection of COVID-19.Cureus. 2022 Sep 13;14(9):e29138. doi: 10.7759/cureus.29138. eCollection 2022 Sep. Cureus. 2022. PMID: 36259008 Free PMC article. Review.
References
-
- Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. Gorbalenya AA, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 2020:536–44. - PMC - PubMed
-
- Malik YA. Properties of Coronavirus and SARS-CoV-2. Malays J Pathol 2020;42(1):3–11. - PubMed
-
- Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367(19):1814–20. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous